AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Merix Bioscience announces cancer vaccines agreement.

Vaccine Weekly

| April 14, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 14 - (NewsRx.com & NewsRx.net) -- Merix Bioscience, a Durham, North Carolina-based company pioneering therapeutic cancer vaccines, has signed a joint licensing agreement with California-based Geron Corp.

The agreement could propel clinical progress and yield faster commercialization of therapeutic cancer vaccines. Clinical testing utilizing the combined technologies is ongoing at Duke University Medical Center in Durham.

In exchange for 5 million shares of Geron stock, valued at over $43 million, Merix will allow Geron the use of its platform technology for modifying dendritic cells to present 1 or more defined antigens in order to provoke an antitumor immune response. Merix retains co-exclusive rights to use the platform technology with defined antigens other than Geron's telomerase antigen and exclusive rights to use it with total tumor RNA and other uncharacterized antigens.

Merix's platform technology has been validated in several clinical trials at Duke, including the ongoing trial which combines Merix's antigen delivery technology with the telomerase antigen.

"This validation of our technology is especially encouraging as we begin ...

Related articles from newspapers, magazines, journals, and more
MERIX Bioscience Appoints Clint G. Dederick, Jr. as Chief Executive Officer.
Press release article from: Business Wire September 16, 2002 700+ words
...BUSINESS WIRE)--Sept. 16, 2002 MERIX Bioscience, Inc., announced today that Clint...Allergenics, Inc., Secretech, Inc. and MERIX Bioscience, Inc. In addition, he has served...served in the U.S. Navy. About MERIX Bioscience, Inc. MERIX Bioscience, Inc. is...
MERIX Bioscience Establishes European Subsidiary.
Press release article from: Business Wire October 11, 2001 700+ words
...BUSINESS WIRE)--Oct. 11, 2001 MERIX Bioscience, Inc. (MERIX) announced today...commercialization." About MERIX MERIX Bioscience, Inc. is a private immunotherapy...30--db/ny* muj CONTACT: MERIX Bioscience, Inc. Mark T. Weedon, 919/287...
MERIX Bioscience Licensed Patent to Use RNA Loaded Cells to Treat Cancers and...
Press release article from: Business Wire November 27, 2001 700+ words
...Durham, N.C.--(BUSINESS WIRE)--Nov. 27, 2001 MERIX Bioscience, Inc. (MERIX) announced today that a core patent has...the most potent immune response possible. About MERIX MERIX Bioscience, Inc. is a private immunotherapy company poised to assume...
Merix Bioscience Changes its Name to Argos Therapeutics; Company Prepares for...
Press release article from: Business Wire October 5, 2004 700+ words
DURHAM, N.C. -- Merix Bioscience today announced the change of its name to Argos Therapeutics...argostherapeutics.com Argos Therapeutics, Inc., formerly Merix Bioscience, is dedicated to becoming a market leader in the field of...
MERIX Bioscience Completes $39.5 Million Private Financing; Company Strengthens...
Press release article from: Business Wire September 10, 2001 700+ words
...DURHAM, N.C.--(BUSINESS WIRE)--Sept. 10, 2001 MERIX Bioscience, Inc. (MERIX) announced today that it has completed...Mark Weedon, President and Chief Executive Officer of MERIX Bioscience. "In the next 12-18 months we hope to initiate and...
Merix Bioscience Launches Trial for New Kidney Cancer Vaccine.
Press release article from: Business Wire June 8, 2004 700+ words
...BUSINESS WIRE)--June 8, 2004 Durham-based Merix Bioscience, a company pioneering therapeutic cancer vaccines, announced...to develop immune-based therapies," Steinman said. Merix Bioscience, Inc. - a privately held company headquartered in Durham...
MERIX Bioscience Appoints World's Leading Dendritic Cell Researchers to Expert...
Press release article from: Business Wire October 11, 2001 700+ words
...DURHAM, N.C.--(BUSINESS WIRE)--Oct. 11, 2001 MERIX Bioscience, Inc. (MERIX) announced today that three of the world...cancer treatment," said Mark Weedon, President and CEO of MERIX Bioscience. The MERIX platform is based on stimulating the patient...
Merix Bioscience Announces Agreement with Geron Corporation for Development of...
Press release article from: Business Wire March 11, 2004 700+ words
...Future Improvements in Treatment of Cancer Durham-based MERIX Bioscience, a company pioneering therapeutic cancer vaccines, has...toward initial clinical trials in both." About Merix Merix Bioscience, Inc. - a privately held company headquartered in Durham...
For more facts and information, see all results

Source: HighBeam Research, Merix Bioscience announces cancer vaccines agreement.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA